Therapeutical combination against cancer
US7070778B2 · kind B2 · utility
11Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2003 |
| Grant date | Jul 4, 2006 |
| Priority date | — |
| Expiry date | Mar 4, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for treating humans and warm-blood animals suffering from cancer. More particularly, a therapeutical treatment in which a monoclonal antibody is administered with either β-(1,3)-glucan like laminarin or a oligo-β-(1,3)-glucan and a pharmaceutically acceptable carrier, to patients suffering from cancer are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.